User profiles for Timo W.M. De Groof

Timo De Groof

Vrije Universiteit Brussel
Verified email at vub.be
Cited by 415

[HTML][HTML] Mechanisms underlying connexin hemichannel activation in disease

…, AR Gomes, TWM De Groof… - International Journal of …, 2021 - mdpi.com
Gap junctions and connexin hemichannels mediate intercellular and extracellular
communication, respectively. While gap junctions are seen as the “good guys” by controlling …

[HTML][HTML] Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs

TWM De Groof, V Bobkov, R Heukers… - Molecular and cellular …, 2019 - Elsevier
The family of G protein-coupled receptors (GPCRs) is the largest class of membrane proteins
and an important drug target due to their role in many (patho)physiological processes. …

Nanobodies detecting and modulating GPCRs outside in and inside out

R Heukers, TWM De Groof, MJ Smit - Current Opinion in Cell Biology, 2019 - Elsevier
G protein-coupled receptors (GPCRs), belonging to the largest class of membrane proteins,
play a prominent role in many (patho)physiological processes and are, therefore, important …

Nanobody-targeted photodynamic therapy selectively kills viral GPCR-expressing glioblastoma cells

TWM De Groof, V Mashayekhi, TS Fan… - Molecular …, 2019 - ACS Publications
Photodynamic therapy (PDT) eradicates tumors by the local activation of a photosensitizer
with near-infrared light. One of the aspects hampering the clinical use of PDT is the poor …

[HTML][HTML] The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth

…, TS Fan, RH de Wit, JR van Senten, TWM De Groof… - Oncogene, 2018 - nature.com
Glioblastoma (GBM) is the most aggressive and an incurable type of brain cancer. Human
cytomegalovirus (HCMV) DNA and encoded proteins, including the chemokine receptor US28…

[HTML][HTML] Selective targeting of ligand-dependent and-independent signaling by GPCR conformation-specific anti-US28 intrabodies

TWM De Groof, ND Bergkamp, R Heukers… - Nature …, 2021 - nature.com
While various GPCRs, including US28, display constitutive, ligand-independent activity, it
remains to be established whether ligand-dependent and -independent active conformations …

Emerging applications of nanobodies in cancer therapy

…, H Valenta, TWM De Groof, Y De Vlaeminck… - International review of …, 2022 - Elsevier
Cancer is a heterogeneous disease, requiring treatment tailored to the unique phenotype of
the patient's tumor. Monoclonal antibodies (mAbs) and variants thereof have enabled …

A few good reasons to use nanobodies for cancer treatment

…, G Raes, TWM De Groof… - European Journal of …, 2023 - Wiley Online Library
mAbs have been instrumental for targeted cancer therapies. However, their relatively large
size and physicochemical properties result in a heterogenous distribution in the tumor …

Current status and future expectations of nanobodies in oncology trials

…, JA Van Ginderachter, TWM De Groof… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Monoclonal antibodies have revolutionized personalized medicine for cancer in
recent decades. Despite their broad application in oncology, their large size and complexity …

Viral G protein–coupled receptors: Attractive targets for herpesvirus-associated diseases

TWM De Groof, EG Elder, M Siderius, R Heukers… - Pharmacological …, 2021 - ASPET
Herpesviruses are ubiquitous pathogens that establish lifelong, latent infections in their host.
Spontaneous reactivation of herpesviruses is often asymptomatic or clinically manageable …